Oncology

An estimated 6.9 million US adults aged 35 years and older had a combined 10.9 million self-reported smoking-attributable medical conditions in 2009.

The vaccine that prevents illness and death from pneumococcal infection also combats severe antibiotic-resistant disease in young children.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.

The FDA today granted priority review status to a breakthrough breast cancer drug developed by Pfizer Inc.

In a retrospective study, investigators found that increases in total cholesterol and triglycerides were associated with an increased risk of biochemical recurrence in prostate cancer.

The drug combination prevents nausea and vomiting after the start of cancer chemotherapy.

The drug combination prevents nausea and vomiting after the start of cancer chemotherapy.

Brand name, patent-protected medications drive increasing costs.

Researcher urges caution in prescribing testosterone therapy in men who have not been diagnosed with hypogonadism.

Tobacco users have an increased risk of oral human papillomavirus type 16, a sexually transmitted virus that is strongly associated with cervical cancer.

Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.

Parents who know about the human papillomavirus are not more likely to get their adolescent daughters vaccinated.

Patients who smoke both traditional and e-cigarettes less likely to quit than those who only smoke traditional cigarettes.

Study finds stringent eligibility criteria is creating a barrier for patient enrollment.

A new metaanalysis suggests that quitting smoking, or even reducing tobacco intake, reduces the risk of dying from prostate cancer.

Therapy significantly reduces development of secondary skin cancer.

A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.

The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.

A combination of Lactobacillus plantarum and a modified inulin derivative reduced expression of T-cells in mammary cancers induced in rats.

RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.

A recent metaanalysis suggests that prediabetes increases the risk of developing certain cancers, particularly in tissues located near the gastrointestinal tract.

RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.

Researchers in Japan are beginning to construct patient-centered counseling techniques for breast cancer by evaluating patient preference.

Amgen has submitted a new drug application to the FDA for its novel leukemia candidate, blinatumomab.

One major challenge in breast cancer is determining which treatment will be most effective for an individual patient's tumor. With a genetic panel, the TAXSig system may help change that.

Protein found to play vital role in development of disease.

Researchers find 23 new prostate cancer risk sites on the genome.

Baldness on front and crown of head linked to increased chance of developing aggressive prostate cancer.